Clinical Trial Update: Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluated inhaled nitric oxide to augment tissue perfusion in sepsis; the study is completed and results were posted in July 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: National Institute of General Medical Sciences (NIGMS) | Conditions: Sepsis | Phase 3 | Status: COMPLETED | Results posted: 2013-07-11